Astrocyte-derived MFG-E8 facilitates microglial synapse elimination in Alzheimer's disease mouse models

Dimitra Sokolova1,2, Shari Addington Ghansah1, Francesca Puletti1

  • 1UK Dementia Research Institute, Institute of Neurology, University College London, Gower Street, London, WC1E 6BT, United Kingdom.

Insights

Astrocytes modulate microglia

Area of Science:

  • Neuroscience
  • Cell Biology
  • Pathology

Background:

  • Synapse loss is an early sign of Alzheimer's disease (AD).
  • Microglia are implicated in synapse loss, but upstream regulators are unknown.
  • Astrocytes are crucial for synapse homeostasis.

Purpose of the Study:

  • Identify upstream modulators of microglia-mediated synapse loss in AD.
  • Investigate the role of astrocytes in regulating microglia-synapse interactions.
  • Determine if astrocytic MFG-E8 can prevent synapse loss in AD models.

Main Methods:

  • Utilized in vitro and in vivo models of AD.
  • Employed viral CRISPR-saCas9 for astrocyte-specific gene knockdown.
  • Analyzed astrocyte morphology and synapse coverage.
  • Measured microglia-synapse engulfment.

Main Results:

  • Identified a distinct subset of reactive astrocytes near synapses in AD models.
  • Demonstrated that these astrocytes upregulate and secrete MFG-E8.
  • Showed that astrocyte-derived MFG-E8 promotes microglia-synapse engulfment.
  • Confirmed that knocking down astrocytic MFG-E8 prevents synapse loss in AD mouse models.

Conclusions:

  • Astrocytes play a critical role in regulating microglia-mediated synapse loss in AD.
  • Astrocyte-microglia communication via MFG-E8 is a key mechanism in early AD pathogenesis.
  • Astrocytic MFG-E8 is a potential therapeutic target for preventing synapse loss in Alzheimer's disease.